UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042245
Receipt number R000046863
Scientific Title Can we prevent pancreatic fistula after distal pancreatectomy by delaying the initiation of food intake? A randomized controlled trial day4 vs day7.
Date of disclosure of the study information 2020/11/30
Last modified on 2021/04/27 18:15:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Can we prevent pancreatic fistula after distal pancreatectomy by delaying the initiation of food intake? A randomized controlled trial day4 vs day7.

Acronym

Can we prevent pancreatic fistula after DP by delaying the initiation of food intake? A randomized controlled trial day4 vs day7.

Scientific Title

Can we prevent pancreatic fistula after distal pancreatectomy by delaying the initiation of food intake? A randomized controlled trial day4 vs day7.

Scientific Title:Acronym

Can we prevent pancreatic fistula after distal pancreatectomy by delaying the initiation of food intake? A randomized controlled trial day4 vs day7.

Region

Japan


Condition

Condition

Patients scheduled to undergo distal pancreatectomy regardless of primary disease, whether open or laparoscopic

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To analyze the impact of the timing of meal initiation after distal pancreatectomy on the incidence of pancreatic fistula incidence using a randomized controlled trial and to establish an appropriate postoperative management plan in our hospital.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of post-operative pancreatic fistula

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

The timing of the initiation of food intake after distal pancreatectomy POD4

Interventions/Control_2

The timing of the initiation of food intake after distal pancreatectomy POD7

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients scheduled to undergo distal pancreatectomy regardless of primary disease, whether open or laparoscopic

Key exclusion criteria

Patients for whom it is deemed necessary to perform a gastrointestinal resection or gastrointestinal anastomosis due to medical reasons

Target sample size

66


Research contact person

Name of lead principal investigator

1st name koji
Middle name
Last name imai

Organization

Asahikawa Medical University

Division name

Hepato-Biliary-Pancreatic and Transplant Surgery

Zip code

0788510

Address

2-1, Midorigaoka-Higashi, Asahikawa, Hokkaido

TEL

0166682503

Email

kimai@asahikawa-med.ac.jp


Public contact

Name of contact person

1st name koji
Middle name
Last name imai

Organization

Asahikawa Medical University Hospital

Division name

Hepato-Biliary-Pancreatic and Transplant Surgery

Zip code

0788510

Address

2-1, Midorigaoka-Higashi, Asahikawa, Hokkaido

TEL

0166682503

Homepage URL


Email

kimai@asahikawa-med.ac.jp


Sponsor or person

Institute

Asahikawa Medical University

Institute

Department

Personal name



Funding Source

Organization

Asahikawa Medical University

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Asahikawa Medical University

Address

2-1, Midorigaoka-Higashi, Asahikawa, Hokkaido

Tel

0166682503

Email

kimai@asahikawa-med.ac,jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

旭川医科大学病院


Other administrative information

Date of disclosure of the study information

2020 Year 11 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 07 Month 09 Day

Date of IRB

2020 Year 10 Month 12 Day

Anticipated trial start date

2020 Year 12 Month 01 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 10 Month 26 Day

Last modified on

2021 Year 04 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046863


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name